Kristian Pietras lab
@kpietraslab.bsky.social
700 followers 430 following 25 posts
We are studying tumor architecture to detail the constituent cell types controlling cancer initiation, spread and treatment response. Located @lund-university.bsky.social
Posts Media Videos Starter Packs
Don’t miss a joint LUCC-LBIC-ZEISS-ACD seminar on visualization of gene expression and biomarker localization in 2D, 3D and 4D. 16th June, BMC, Lund.
Reposted by Kristian Pietras lab
🚨 We’re hiring a bioinformatics-focused PhD student for our ERC-funded project on recurrent GBM! Focus: tumor-supportive microenvironment 🔬 Experience with scRNA-seq, spatial transcriptomics & Python/R a plus. Must be self-motivated & driven. DM for details! Repost=❤️ lu.varbi.com/en/what:job/...
Doctoral Student in Tumor Biology
Description of the workplace The research group conducts experimental research on brain tumors and is led by Associate Professor Alexander Pietras. The group consists of a bioinformatician, two postdo
lu.varbi.com
Swedish Childhood Cancer Fund (BCF) is raising awareness and support: today it is #Fotbollströjefredagen (Football shirt Friday)
Join us for innovative explorations of the tumor microenvironment🔬 Learn cutting-edge technologies and grow in a dynamic environment💡 The postdoc will work alongside a doctoral student from @adaptmet.bsky.social, gaining access to collaborative partners across 🇪🇺.
Apply now👇
tinyurl.com/4mby45hf
Postdoc in Experimental Oncology - Lund (Stad), Skåne (SE) job with Lund University | 12838990
Lunds universitet, 009999 LUNDS UNIVERSITET, 310000 MED Lund University was founded in 1666 and is repeatedly ranked among the world’s top universi...
tinyurl.com
Reposted by Kristian Pietras lab
Targeting the most immune-suppressive macrophage with ALK1 inhibitors in malignant breast cancer!
@kpietraslab.bsky.social & team @lund-university.bsky.social target the most immune-suppressive macrophage with ALK1 inhibitors in malignant breast cancer models!
buff.ly/FXssb1x
We are proud to share that our PI has been named Cancer Researcher of the Year by @Cancerfonden! This well-deserved recognition highlights not only his outstanding contributions to cancer research but also his creativity in tackling scientific challenges and his inspiring leadership within our team.
Kristian Pietras – Årets cancerforskare 2025
Kristian Pietras forskar om hur celler i blodkärl och bindväv påverkar cancerns möjlighet att växa eller dö. Nu tilldelas han utmärkelsen Årets cancerforskare.
www.cancerfonden.se
Reposted by Kristian Pietras lab
🎉 Today, we gathered online for the #AdaptMet Kick-Off Meeting! A fantastic start to this journey, bringing together top researchers & partners to train the next generation of metastasis experts. Exciting discussions & collaborations ahead—stay tuned! 🔬✨ #CancerResearch
At the Brain Tumor Microenvironment Symposium @institutducerveau.bsky.social, Sebastian Braun presented our comprehensive study of pericytes in GBM 🤩. Pericytes act as guardians of the peri-vascular niche to prevent malignant cell invasion, read more at www.biorxiv.org/content/10.1...
@jessicapantaleo.bsky.social making us proud at the @lund-university.bsky.social Cancer Centre Tumor Microenvironment retreat by presenting our latest findings on CAF subtype spatial organization across longitudinally sampled experimental breast cancers.
Finally, we send our gratitude to all funders
@lund-university.bsky.social , @vetenskapsradet.bsky.social @kawresearch.bsky.social, Cancerfonden, Region Skåne, The Göran Gustafsson Foundation, The Mats Paulsson Foundations, Cancera, The Crafoord Foundation, and the Fru Berta Kamprad Foundation.
6/6
Last chance to apply, call closes on Jan 17th!
We are live 🕺! Recruitment for the exciting MSCA doctoral network Adaptmet is now open. Join us and great collaborators across Europe to explore fundamental mechanisms of metastatic dissemination:
adaptmet.eu/recruitment/
Recruitment
Recruitment is now open! Apply for one of the 16 positions availablein the Adaptmet network and build your futureas a researcher in metastasis! Adaptmet is offering generous three-year fellowship...
adaptmet.eu
Incredible skills, knowledge, endurance, passion, and joy went into the making of this study by main authors @matteobocci.bsky.social, Mehrnaz Safaee-Talkhoncheh, and Jonas Sjölund. We also thank all co-authors, and especially acknowledge the work of undergraduate and graduate students.
5/6
ALK1 inhibition acted in a multimodal manner to suppress breast cancer metastatic dissemination to the lung by: 1) Interfering with the differentiation and release of monocytes in the bone marrow and 2) Reducing the mobilization of immunosuppressive macrophages across the endothelial barrier.
3/6
When we set out on this journey, we did not expect to delve into tumor immunology, but the unanticipated expression of ALK1 on a subset of highly immunosuppressive macrophages led us to detail a role for ALK1 at the crossroads between tumor angiogenesis and immunity.
2/6
We have been waiting impatiently but can finally share our latest efforts in understanding the biology of the TGF-beta type I receptor ALK1 (gene name ACVRL1), see graphical abstract in post and the full article here: www.jci.org/articles/vie...
1/6
The two Pietras labs @pietraslab.bsky.social @kpietraslab.bsky.social collide in a fierce game of Ping Pong. The losers fill all pipette tip boxes the next year 😜
Reposted by Kristian Pietras lab
Kristian Pietras @kpietraslab.bsky.social at Lund University @lunduniversity.bsky.social will oversee DC4 who will work on the suppression of metastatic dissemination through precision targeting of cancer-associated fibroblast niches